Chad Stapp, DPM
Podiatrist · Aberdeen, SDNPI 1952438996
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Smith+Nephew at 27.4% of the total. Reporting peaked in 2019 at $285 and has fallen 97.0% since, to $9 in 2025.
Across 20 payments — averaging $35.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$194
- Organogenesis Inc.$152
- Flower Orthopedics Coporation$92
- Arthrex$88
- Integra Lifesciences Corporation$61
- Osiris Therapeutics Inc.$30
- plus $94 from 5 others
What the payments were for
- Speaking & faculty fees$517%
- Food & beverage$66093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $194 |
| Organogenesis Inc. | 5 | $152 |
| Flower Orthopedics Coporation | 1 | $92 |
| Arthrex | 1 | $88 |
| Integra Lifesciences Corporation | 1 | $61 |
| Osiris Therapeutics Inc. | 2 | $30 |
| KCI USA, Inc. | 2 | $27 |
| Medline Industries LP | 1 | $23 |
| Innovation Technologies Inc | 1 | $20 |
| Stryker | 1 | $15 |
| Kerecis Limited | 1 | $9 |
How this compares
Too few podiatrist providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $468 |
| Methylprednisolone | 49 | $372 |
| Cephalexin | 30 | $178 |
| Diclofenac Sodium | 11 | $138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $113 |
| Doxycycline Hyclate | 21 | $111 |
| Tramadol Hcl | 28 | $81 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Aberdeen
- Brian DixSioux Falls$48K
- Anthony DoyonRapid City$5K
- Rylan JohnsonRapid City$3K
- Jordan FinckHuron$2K
- Mark GraeberSioux Falls$1K
- Carolyn StansberrySpearfish$1K
- Michael McGowanSioux Falls$1K
- David LonbakenPierre$973
- Kent RenaudRapid City$704
- Christine WiardaYankton$450
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.